Categories: Analysts

Kinaxis off to solid start to life as public company, says Cormark

Cormark analyst Richard Tse says Kinaxis is a high quality new public entry in Canada, and everything he sees from the company’s Q2 strengthens his belief that its solid underlying financials are not priced into its stock.

Its first set of results as a public company underscore all the reasons he initiated coverage of Kinaxis (TSX:KXS) earlier this month with a “Buy” rating, says Cormark analyst Richard Tse.

Last Thursday, Kinaxis reported its Q2, 2014 results. The company lost (U.S.) $5.3-million on revenue of $17.9-million, a topline that was up 14% from the same period last year.

CEO Doug Colbeth reflected on he company’s recent IPO.

“The success of our initial public offering underscores the market’s positive view of our unique SaaS (software-as-a-service) offering and the growth potential it represents,” he said. “The complexity and importance of supply chain management in today’s global economy provides us with a large addressable market. Our focus is growing subscription revenues through new customers, verticals and applications to drive cash flow.”

Tse says Kinaxis is a high quality new public entry in Canada, and everything he sees from the company’s Q2 strengthens his belief that its solid underlying financials are not yet priced into its stock. Enterprises are accelerating their move to the cloud and Kinaxis is “positioned at the heart of this enterprise application renaissance”, he says.

The Cormark analyst says he sees a short term investment period for Kinaxis that will result in EBITDA margins in the 20% to 25% range. He believes that the company will do in the SaaS-based supply chain management (SCM) space what Salesforce.com did in the customer relationship management (CRM) space, that is, disrupt is greatly.

In a research update to clients this morning, Tse reiterated his Buy rating and $22.00 one-year target on Kinaxis.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: kxs
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

18 mins ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

16 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

23 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

23 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

1 day ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago